NCT04449237

Brief Summary

This project aims to systematically and deeply study the central mechanism of tinnitus using electroencephalogram, and further study the treatment mechanism of tinnitus in combination with sound treatment strategies, so as to provide a research basis for clinical treatment of tinnitus.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jul 2020

Typical duration for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 16, 2020

Completed
10 days until next milestone

First Posted

Study publicly available on registry

June 26, 2020

Completed
5 days until next milestone

Study Start

First participant enrolled

July 1, 2020

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2022

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2023

Completed
Last Updated

July 7, 2020

Status Verified

July 1, 2020

Enrollment Period

2 years

First QC Date

June 16, 2020

Last Update Submit

July 2, 2020

Conditions

Outcome Measures

Primary Outcomes (8)

  • electroencephalogram evaluation

    latency

    From date of randomization, assessed every 3 month, up to 24 month

  • electroencephalogram evaluation

    peak

    From date of randomization, assessed every 3 month, up to 24 month

  • electroencephalogram evaluation

    amplitude

    From date of randomization, assessed every 3 month, up to 24 month

  • the loudness of tinnitus

    estimated by auditory facility, recorded by unit of dB

    From date of randomization, assessed every 3 month, up to 24 month

  • the frequency of tinnitus

    estimated by auditory facility, recorded by unit of Hz

    From date of randomization, assessed every 3 month, up to 24 month

  • minimum masking level

    the minimum volume to masking tinnitus, recorded by unit of dB

    From date of randomization, assessed every 3 month, up to 24 month

  • Tinnitus Handicapped Inventory

    Tinnitus disability is divided into four levels, the first level: 0-16 points, no disability; Level 2:18-36, slightly disabled; Level 3:38-56, moderate disability; Level 4:58-100, severe disability.

    From date of randomization, assessed every 3 month, up to 24 month

  • Hospital Anxiety and Distress Scale

    0-7 are asymptomatic; 8 -10 respectively belong to suspicious existence; 11 -21 must exist.

    From date of randomization, assessed every 3 month, up to 24 month

Study Arms (3)

volunteer

OTHER

40 volunteer will not accept any treatment

Other: music therapy

patients with unmodified music group

PLACEBO COMPARATOR

40 participants in this group will listen to music without any modification

Other: music therapy

patients with modified tinnitus relieving music

EXPERIMENTAL

40 participants in this group will listen to the music modified according to the matched dominant tinnitus pitch

Other: music therapy

Interventions

music therapy: therapeutic sound according to the frequency and loudness of each patient's tinnitus sound, so as to reduce the tinnitus sound.

patients with modified tinnitus relieving musicpatients with unmodified music groupvolunteer

Eligibility Criteria

Age18 Years - 30 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • years old, male or female;
  • PTA (0.5,1,2kHz) ≤25dB HL;
  • Tinnitus is a major problem faced by patients (except healthy volunteers);
  • tinnitus course \> for 3 months;
  • Healthy, no history of other ear diseases, no history of hearing impairment;
  • There are no other medical, psychological or social problems that need urgent treatment, and no other problems that interfere with tinnitus-related treatment;
  • Voluntary tinnitus treatment, and have enough time to cooperate with treatment.

You may not qualify if:

  • Pulsatile tinnitus;
  • Acute tinnitus;
  • Tinnitus is associated with severe hearing loss;
  • Tinnitus accompanied by vertigo;
  • Tinnitus accompanied by headache;
  • Tinnitus is accompanied by somatic symptoms, such as neck pain and temporomandibular joint disorder;
  • Post-traumatic tinnitus;
  • Tinnitus is associated with serious psychiatric complications;

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Tinnitus

Interventions

Music Therapy

Condition Hierarchy (Ancestors)

Hearing DisordersEar DiseasesOtorhinolaryngologic DiseasesSensation DisordersNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Sensory Art TherapiesComplementary TherapiesTherapeuticsRehabilitationAftercareContinuity of Patient CarePatient CarePsychotherapyBehavioral Disciplines and Activities

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 16, 2020

First Posted

June 26, 2020

Study Start

July 1, 2020

Primary Completion

June 30, 2022

Study Completion

June 30, 2023

Last Updated

July 7, 2020

Record last verified: 2020-07

Data Sharing

IPD Sharing
Will not share